Rama Phosphates profit and loss

Latest FY26

Revenue: ₹893cr+20.1% on FY25
EBITDA: ₹87.5cr+101.4% on FY25
Net profit: ₹52.7cr+285.5% on FY25
EPS: ₹14.90+286.0% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Expenses
	928	893	744	603	875
	1.9	1.4	3.5	1.0	0.7
	929	894	747	604	875
	622	580	485	509	672
	29.1	31.4	11.9	2.8	1.0
	−23.7	−5.9	23.3	−30.2	−32.3
	38.7	38.1	35.0	32.1	34.1
	11.2	10.7	13.2	12.8	8.1
	7.7	7.9	8.2	9.0	9.9
	172	162	145	110	128
	858	824	722	645	821
	88.6	87.5	43.4	−20.4	72.2
	80.9	79.6	35.2	−29.4	62.3
Profit
	71.7	70.3	25.6	−41.2	54.9
	71.7	70.3	25.6	−41.2	54.9
	18.1	14.0	5.4	0.0	13.7
	−0.2	3.5	6.5	−10.1	0.3
	17.9	17.6	11.9	−10.1	13.9
	53.7	52.7	13.7	−31.1	40.9
	53.7	52.7	13.7	−31.1	40.9
	−0.1	−0.1	4.7	76.7	−0.2
	53.7	52.6	18.4	45.6	40.8
Per share
	₹15.18	₹14.90	₹3.86	−₹17.56	₹23.14
	₹15.18	₹14.90	₹3.86	−₹17.56	₹23.14
Profit build-up — alternate / pre-Ind-AS tags
	—	—	25.6	—	—
	—	—	18.8	—	—
	—	—	13.7	—	—
Continuing & discontinued operations
	—	—	13.7	—	—
Other comprehensive income — detail
	−0.1	−0.1	4.7	—	—
	−0.2	−0.2	−0.5	94.9	−0.2
	−0.1	−0.1	−5.3	—	—
	—	—	—	18.2	−0.0
Per share — as-filed variants
	₹15.18	₹14.90	₹3.86	−₹17.56	₹23.14
	₹15.18	₹14.90	₹3.86	−₹17.56	₹23.14
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	300	287	223	121	234
	32.3%	32.2%	30.0%	20.1%	26.7%
Adjusted (ex-exceptional items) — derived
	71.7	70.3	25.6	−41.2	54.9
	53.7	52.7	13.7	−31.1	40.9
	₹15.18	₹14.90	₹3.86	−₹17.56	₹23.14

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

RAMAPHO₹99.00

Rama Phosphates Limited

· Chemicals

Annual Quarterly₹ CrorePeersKHAICHEM ARIES ZUARI MADRASFERT SPICMcap ₹350 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	874.8	603.2	743.7	893.0	927.5
Other Income	0.7	1.0	3.5	1.4	1.9
Total Income	875.5	604.2	747.2	894.4	929.4
Expenses
+ Cost of Materials Consumed	672.4	509.1	485.5	580.5	622.5
+ Purchases of Stock-in-Trade	1.0	2.8	11.9	31.4	29.1
+ Changes in Inventories	-32.3	-30.2	23.3	-5.9	-23.7
+ Employee Benefit Expense	34.1	32.1	35.0	38.1	38.7
+ Finance Costs	8.1	12.8	13.2	10.7	11.2
+ Depreciation & Amortisation	9.9	9.0	8.2	7.9	7.7
+ Other Expenses	127.6	109.8	144.6	161.6	172.3
Total Expenses	820.6	645.4	721.7	824.1	857.8
EBITDA	72.2	-20.4	43.4	87.5	88.6
EBIT	62.3	-29.4	35.2	79.6	80.9
Profit
PBT before Exceptional Items	54.9	-41.2	25.6	70.3	71.7
Pretax Income	54.9	-41.2	25.6	70.3	71.7
+ Current Tax	13.7	0.0	5.4	14.0	18.1
+ Deferred Tax	0.3	-10.1	6.5	3.5	-0.2
Tax Expense	13.9	-10.1	11.9	17.6	17.9
Net Income	40.9	-31.1	13.7	52.7	53.7
+ Net Income — Continuing Ops	40.9	-31.1	13.7	52.7	53.7
+ Other Comprehensive Income	-0.2	76.7	4.7	-0.1	-0.1
Total Comprehensive Income	40.8	45.6	18.4	52.6	53.7
Per Share
Basic EPS	23.14	-17.56	3.86	14.90	15.18
Diluted EPS	23.14	-17.56	3.86	14.90	15.18
Profit Build-up — Alternate / Pre-Ind-AS Tags
PBT before Exceptional & Extraordinary Items	—	—	25.6	—	—
+ Adjustments to Profit / (Loss)	—	—	18.8	—	—
Profit for the Period before Minority Interest	—	—	13.7	—	—
Continuing & Discontinued Operations
Profit from Continuing Operations	—	—	13.7	—	—
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	4.7	-0.1	-0.1
+ Items NOT to be Reclassified to P&L	-0.2	94.9	-0.5	-0.2	-0.2
+ Tax on Items NOT to be Reclassified	—	—	-5.3	-0.1	-0.1
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	18.2	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	23.14	-17.56	3.86	14.90	15.18
Diluted EPS — Continuing Operations	23.14	-17.56	3.86	14.90	15.18
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	233.8	121.4	223.1	287.1	299.6
Gross Margin %	26.73	20.13	30.00	32.15	32.31
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	54.9	-41.2	25.6	70.3	71.7
Net Income Adj (tax-effected)	40.9	-31.1	13.7	52.7	53.7
EPS Adj	23.14	-17.56	3.86	14.90	15.18
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	5.00	5.00	5.00
Filed Debt Equity	—	—	0.33	0.32	0.37
Filed Dscr	—	—	2.04	4.74	4.29
Filed Iscr	—	—	3.56	7.59	6.63
Paid Up Equity Capital	17.7	17.7	17.7	17.7	17.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.